JIM MURPHY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2008-10-30 Jim Murphy(9) Includes options to purchase 120,000 shares of common stock, which are exercisable within 60 days of October 24, 2008 (December 23, 2008) and 10,000 shares of unvested restricted common stock granted in 2005, which vest in equal annual installments over a four-year period, all of which are subject to transfer and forfeiture restrictions.
2010-11-12 Jim Murphy(6) Includes options to purchase 307,500 shares of common stock, which are exercisable within 60 days of October 29, 2010 (December 28, 2010).
2011-02-18 James B. Murphy Vice President and Chief Financial Officer
2012-11-19 Jim Murphy(5) — * (5) Mr. Murphy's employment with the company ended March 31, 2012.

Data sourced from SEC filings. Last updated: 2025-10-12